LUNG METASTASIS AND PANCREATIC METASTASIS AT 4 YEARS AND 11 YEARS AFTER NEPHRECTOMY FOR RENAL CELL CARCINOMA

  • TSUCHIYA Masaru
    Division of General and Gastroenterological Surgery, Department of Surgery (Omori), Toho University School of Medicine
  • KANEKO Hironori
    Division of General and Gastroenterological Surgery, Department of Surgery (Omori), Toho University School of Medicine
  • OTSUKA Yuichiro
    Division of General and Gastroenterological Surgery, Department of Surgery (Omori), Toho University School of Medicine
  • TAMURA Akira
    Division of General and Gastroenterological Surgery, Department of Surgery (Omori), Toho University School of Medicine
  • MAEDA Tetsuya
    Division of General and Gastroenterological Surgery, Department of Surgery (Omori), Toho University School of Medicine
  • SHIBUYA Kazutoshi
    First Department of Pathology, Toho University School of Medicine

Bibliographic Information

Other Title
  • 腎癌術後4年目に肺転移,11年目に膵転移をきたした1例

Search this article

Abstract

We report a case of a 67-year-old woman who was admitted following the discovery of a mass lesion in the pancreas on abdominal ultrasonography. The patient had undergone right nephrectomy for renal cell carcinoma (RCC) 11 years previously, and bilateral partial lobectomy of lung for metastasis tumor from RCC 7 years ago. Abdominal echo showed hypervascular masses in the pancreatic body that were mostly probably metastatic lesions from RCC. She underwent a distal pancreatectomy. Histological examination of the specimen revealed metastatic tumor from RCC, which was diagnosed as clear cell carcinoma. She has been treated by IL-2 for recurrent lung lesion and has been living for 25 months after the operation with no evidence of metastasis. For a patient with hypervascular mass who has undergone surgery for RCC previously, we should consider that it might be metastasis from RCC. It takes a long time after surgery for RCC for pancreatic metastasis to occur therefore a long period of observation is neaded. It is suggested that aggressive surgery for metastatic pancreatic tumor from RCC would be a favorable option.

Journal

Citations (1)*help

See more

References(23)*help

See more

Details 詳細情報について

Report a problem

Back to top